India’s pharmaceutical exports have reached a record value of ₹2.72 lakh crore, equivalent to over US$30 billion, reflecting sustained global demand for medicines and healthcare products manufactured in the country. Commerce Secretary Rajesh Agrawal highlighted that this performance underscores the resilience and strength of India’s pharmaceutical industry in international markets.
He noted that exports have been driven by steady demand for vaccines, generic medicines, bulk drugs and a wide range of therapeutic products. Growth has been supported by expanded manufacturing capacities, cost competitiveness, adherence to stringent quality benchmarks and strong regulatory compliance by Indian pharmaceutical companies, particularly in regulated and semi-regulated markets.
According to the Commerce Secretary, the achievement of ₹2.72 lakh crore in pharmaceutical exports points to consistent growth across multiple product categories, including formulations, active pharmaceutical ingredients and vaccines. The rising export value also reflects deeper integration of India’s pharma sector into the global healthcare supply chain.
The industry’s increasing contribution to India’s foreign exchange earnings and the development of a diversified export base have helped cushion the sector against cyclical slowdowns in specific regions. Demand from both established and emerging markets has continued to support export momentum.
The expanding role of Indian pharmaceutical manufacturers as reliable suppliers of quality-assured healthcare products has reinforced the country’s position in global trade. The export performance highlights India’s growing standing as a dependable partner in meeting worldwide healthcare requirements while contributing to overall economic activity through higher trade volumes.
Summary
India’s pharmaceutical exports have crossed ₹2.72 lakh crore, or over US$30 billion, supported by strong global demand for vaccines, generics and bulk drugs. The milestone reflects improved manufacturing capacity, quality compliance and deeper integration of the sector into the global healthcare supply chain, as highlighted by Commerce Secretary Rajesh Agrawal.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.